NCT06292624

Brief Summary

Consequences of the compromised vascular system in diabetes mellitus (DM) are among the most devastating complications. Reduction in blood flow and oxygen uptake of skeletal muscle leads to muscle fatigue and impaired skeletal muscle post-exercise adaptation. Recent studies showed that intermittent vacuum therapy (IVT) augments the blood flow of the foot in people with DM. This pilot study investigates the effects of combined IVT and aerobic exercise in improving lower limb muscle oxygenation and distal circulation in individuals with DM. Positive results of the study shed light on strategy that enhances the effectiveness of aerobic exercise in people with DM.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
12

participants targeted

Target at below P25 for not_applicable diabetes-mellitus

Timeline
Completed

Started Aug 2023

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2023

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

February 27, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 5, 2024

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2025

Completed
Last Updated

March 12, 2025

Status Verified

February 1, 2025

Enrollment Period

1.7 years

First QC Date

February 27, 2024

Last Update Submit

March 9, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Muscle oxygenation

    Two wireless NIRS (Near-infrared Spectroscopy) sensors (Portamon, Artinis Medical Systems,The Netherlands) will be placed on participants' dorsal feet and quadriceps on their dominant leg. The signal will be collected continuously for 10 minutes during cycling.

    baseline

  • Muscle oxygenation

    Two wireless NIRS sensors (Portamon, Artinis Medical Systems,The Netherlands) will be placed on participants' dorsal feet and quadriceps on their dominant leg. The signal will be collected continuously for 10 minutes during cycling.

    post-treatment (6weeks)

Secondary Outcomes (8)

  • Surface Electromyography

    baseline

  • Surface Electromyography

    post-treatment (6weeks)

  • Foot Sensation

    baseline

  • Foot Sensation

    post-treatment (6weeks)

  • Functional muscle strength

    baseline

  • +3 more secondary outcomes

Study Arms (1)

Intermittent vacuum therapy + Cycling exercise

EXPERIMENTAL

Participants received 12 IVT sessions of 30 minutes combined with 20 minutes of cycling exercise during the 6-week period.

Device: Intermittent vacuum therapy (Weyergans High Care® Medial, Germany)Behavioral: Cycling exercise

Interventions

The participants' lower limb will be placed in the vacuum chamber and sealed with a cuff. The maximum negative pressure applied in the experimental group would be -40mmHg (negative pressure/ambient pressure phase: 9s / 7s). The parameters are selected based on the manufacturer's recommendations.

Intermittent vacuum therapy + Cycling exercise

The participant will perform 20 minutes of cycling exercise. Aiming at reaching a moderate exercise intensity (50% - 70%) of maximal heart rate on a gym bike.

Intermittent vacuum therapy + Cycling exercise

Eligibility Criteria

Age55 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age between 55 and 80 years old,
  • being diagnosed with Type 2 DM,
  • being able to give informed consent to participate in the study.
  • able to walk without assistance

You may not qualify if:

  • have a conditions that contraindications to IVT: pregnancy, abdominal wall hernia, recent (\<8 weeks) trauma of the lower limbs,
  • have an open wound on the lower extremity or with lower extremity infection,
  • have any orthopaedic or medical conditions that could hinder the assessment and training.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Hong Kong Polytechnic University

Hong Kong, Hong Kong

Location

MeSH Terms

Conditions

Diabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Clinical trials with a single arm, receiving IVT combined with cycling exercise
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 27, 2024

First Posted

March 5, 2024

Study Start

August 1, 2023

Primary Completion

April 30, 2025

Study Completion

April 30, 2025

Last Updated

March 12, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared to other researchers

Locations